Financial News
Latest News about ITOS
Recent news which mentions ITOS
3 Biotech Stocks With Big Catalysts Around the Corner
April 10, 2021
From Motley Fool
10 Biggest Price Target Changes For Tuesday
April 06, 2021
From Benzinga
The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight
April 03, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 19, 2021
From Benzinga
65 Biggest Movers From Yesterday
March 16, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
March 03, 2021
From Benzinga
The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
March 03, 2021
From Benzinga
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
February 23, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 18, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For October 8, 2020
October 08, 2020
From Benzinga
The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO
September 02, 2020
From Benzinga
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
August 19, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For August 18, 2020
August 18, 2020
From Benzinga
The Daily Biotech Pulse: Poseida's Phase 1 Study Placed On Clinical Hold, Orphan Drug Designation For Krystal Biotech, Tiziana's Patent Award
August 18, 2020
From Benzinga
The Week Ahead In Biotech: Spotlight On Gilead, BioMarin FDA Decisions, Biotech IPOs
August 16, 2020
From Benzinga
The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal
August 14, 2020
From Benzinga
The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller
August 13, 2020
From Benzinga
The Daily Biotech Pulse: India Globalization Gets Nod For Alzheimer's Trial, Moderna's Vaccine Deal With US, Cellular Biomedicine To Go Private
August 12, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
August 06, 2020
From Benzinga
90 Biggest Movers From Yesterday
August 06, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
